Study of Individualized, Precise and Standardized Cervical Open-door Surgery for Cervical Spinal Stenosis
Launched by XIJING HOSPITAL · Mar 23, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of surgery called "open-door posterior cervical surgery" specifically designed for patients with cervical spinal stenosis, a condition where the spinal canal in the neck narrows, potentially causing pain and other symptoms. The goal is to see if this personalized and standardized approach to surgery can safely and effectively help patients who need treatment for this condition. The researchers are currently looking for participants to join the study.
To be eligible for the trial, participants should be between 28 and 85 years old and diagnosed with specific types of neck problems that require surgery. It's important that they do not have certain exclusions, like severe neck instability or other serious health issues that might affect the surgery's results. If you join the trial, you'll receive care from a specialized team, and your progress will be closely monitored. This study aims to provide valuable information that could help improve treatment options for others with similar conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The age of 28-85 years old; Through systematic clinical and imaging examination, patients diagnosed with C3-7 multilevel cervical spondylitis myelopathy or cervical spinal stenosis who need to undergo posterior cervical open-door surgery.
- • No contraindications in preoperative routine tests and examinations.
- • Informed consent of patients.
- Exclusion Criteria:
- • Cervical radiculopathy
- • Cervical kyphosis or instability
- • Cervical spondylosis caused by trauma, tumor, tuberculosis and metabolic diseases
- • Revision surgery or combined anterior-posterior surgery is required
- • Serious neurological diseases affect the postoperative effect evaluation
- • Mental illness cannot cooperate with follow-up
- • Contraindications for MRI examination
- • Patients themselves or their families do not agree to participate in the study
- • Other situations that are not suitable for study participation.
About Xijing Hospital
Xijing Hospital, a prominent medical institution affiliated with the Fourth Military Medical University in Xi'an, China, is dedicated to advancing healthcare through innovative clinical research. Renowned for its comprehensive range of medical services and expertise in various specialties, Xijing Hospital actively sponsors clinical trials aimed at evaluating new therapies, improving patient outcomes, and contributing to scientific knowledge. With a commitment to ethical standards and patient safety, the hospital fosters collaboration among multidisciplinary teams to drive forward the development of effective treatment options that address critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Xi'an, , China
Xi'an, Shannxi Province, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials